Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2021 / May / Lessons from the Octopus Teacher
Research & Innovations Retina Health Economics and Policy

Lessons from the Octopus Teacher

What does a colorblind octopus have to do with treating age-related macular degeneration?

By Aleksandra Jones 5/20/2021 1 min read

Share

A research project led by Shelby Temple, Honorary Professor at Aston University and Bristol University, UK, measured the way octopuses can detect polarized light invisible to humans (1). Octopuses are colorblind, but the study showed that they have developed the most sophisticated and sensitive polarization vision system of any animal tested so far.

Temple explained, “We knew that octopuses, like many marine species, could see patterns in polarized light much like we see color, but we had no idea that they could do so when the light was only 2 percent polarized – that was an exciting surprise, but even more surprising was when we then tested humans and found that they were able to see polarization patterns when the light was only 24 percent polarized (2).”

This discovery led to the development of a new medical device, which identifies people at greater risk of developing age-related macular degeneration. The novel technology screens people for low macular pigments – carotenoids lutein, zeaxanthin, and meso-zeaxanthin – that act as a natural defense against damaging violet-blue light. These pigments can only be acquired from diet (from foods such as cantaloupe, pasta, corn, carrots, orange and yellow peppers, fish, and eggs) and offer long-term protection of the retina. Macular pigments prevent AMD by acting as antioxidants and by actively absorbing high-energy visible violet-blue wavelengths before they reach the retina. According to Temple, “Humans can perceive polarized light because macular pigments in our eyes differentially absorb violet-blue light depending on its angle of polarization, an effect known as Haidinger’s brushes. It’s like a super sense most of us don’t even know we have, revealing a faint yellow bowtie shape on the retina. The more of these pigments a person has, the better protected they are against sight loss.”

The new testing method enables eye care professionals to suggest appropriate lifestyle choices to people at more risk of developing AMD, such as wearing sunglasses and eating more pigment-rich foods to help prevent their eyesight.

References

  1. SE Temple, J Exp Biol, 224 (2021). PMID: 33602676.
  2. University of Bristol (2021). Available at: https://bit.ly/3fAvQjx.

About the Author(s)

Aleksandra Jones

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

More Articles by Aleksandra Jones

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: